Rezolute is proud to announce the appointment of?Erik Harris, a seasoned rare disease commercial leader, to our Board of Directors. With over two decades of biopharma experience, including global product launches and commercial strategy, Erik joins at a critical time in our mission to transform care for individuals with hyperinsulinism. ?Learn more:?https://bit.ly/4izZvc2. #Leadership #RareDisease #RezoluteBio #BiotechLeadership #WeAreRezolute
Rezolute, Inc.
生物技术研究
Redwood City，California 9,326 位关注者
Rezolute is developing transformative therapeutics for rare and metabolic diseases.
关于我们
Rezolute is a late-stage rare disease company focused on significantly improving outcomes for individuals with hypoglycemia caused by hyperinsulinism (HI). For more information, visit: www.rezolutebio.com.
- 网站
-
https://www.rezolutebio.com
Rezolute, Inc.的外部链接
- 所属行业
- 生物技术研究
- 规模
- 51-200 人
- 总部
- Redwood City，California
- 类型
- 上市公司
地点
-
主要
获取路线
275 Shoreline Dr.
Ste. 500
US，California，Redwood City，94065
Rezolute, Inc.员工
动态
-
We're #hiring a new Associate / Senior Associate Regulatory Affairs - Regulatory Operations in Redwood City, California. Apply today or share this post with your network.
-
Global, Multi-Center, Repeat-Dose, Phase 2 Study of RZ358 (Ersodetug), an Insulin Receptor Antibody, for Congenital Hyperinsulinism We are pleased to share the findings from our global, multi-center Phase 2b study (RIZE) evaluating RZ358 (ersodetug) in patients with congenital hyperinsulinism (cHI) in a detailed paper published today in Med by Cell Press. The study demonstrated that ersodetug was generally safe, well-tolerated, and led to clinically meaningful improvements in glycemic control, particularly at higher dose levels. These results support the potential of ersodetug as a targeted therapy for cHI, addressing a significant unmet medical need. For detailed insights, read the full paper: https://bit.ly/4hGNyzS. #WeAreRezolute #RareDiseases #CongenitalHyperinsulinism #Hypoglycemia #ClinicalTrial
-
We're #hiring a new Senior Manager /Associate Director Clinical Supply Chain in Redwood City, California. Apply today or share this post with your network.
-
Are you ready to take your career to the next level? Rezolute is seeking passionate professionals to help us advance solutions for rare diseases. Learn about our opportunities: https://lnkd.in/gn9nRV4M. #WeAreRezolute #CareersInHealthcare #JoinOurMission
-
Spending #RareDiseaseDay2025 with colleagues in Lisbon taking part in the Congenital Hyperinsulinism International‘s Collaborative Research Network meeting. #RezoluteCaresAboutRare
-
-
It's #RareDiseaseDay2025! Learn more: https://rarediseaseday.org. Rezolute is advancing innovative treatments to help improve the lives of people living with congenital and tumor hyperinsulinism. #WeAreRezolute #RareDisease
-
-
It is Rare Disease week!
The path from research to reality is filled with challenges, from policy uncertainty, funding gaps, and regulatory hurdles. Companies like Rezolute are driving solutions forward. Rezolute, Inc. is a leader among small rare disease companies fighting for real progress this #RareDiseaseWeek and beyond.
-
-
Rezolute is committed to equipping healthcare providers with the tools and treatments needed to address hyperinsulinism effectively. Explore our clinical trials and innovative solutions at rezolutebio.com. #WeAreRezolute #RareDisease #HealthcareLeadership
-
-
We're #hiring a new Director Medical Affairs in Redwood City, California. Apply today or share this post with your network.